2Coletle D, Foure S, Fizames C, et al.. A comprehensive genetic map of the human genome based on 5 264 mlcrosatenites, Nature, 1996.380 : 152 - 155.
3Marhall E. Human Genome Project: The hunting of the SPN. Science, 1997. 278:2074 -2078.
4Bouffard GG, Idol JR, Braden VV, et al.. A physical map of human chromosome 7 : an integrated YAC contig map with average STS spacing of 79kb. Genome Res. 1997, 7:673 - 678.
5Schuler GD, Bogusk MS, Stewart EA, et al.. A gene map of the human genome. Science, 1996, 277:540 - 546.
6Spear BB.. Viewpoint - pharmacogenomics: today, tomorrow, and beyond, Drug Benefit Trends, 1999, 11 : 53 -54.
7Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 1996, 6 : 1 - 42.
8Eichelbaum M, Evert B. Influence of pharmacogenetics on drug disposition and responses, Clinical and Experimental Pharmacology and Physiology, 1996, 23:983-985.
9Kaneko A, Lum JK, Yaviong J, et al. High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. Pharmacogenetics, 1999,9:581-590.
10Linder MW, Prough RA, Valdes RJ. Pharmacogenetics - a laboratory tool for optimizing therapeutic efficiency, Clinical Chemistry., 1997, 43:254 - 266.
